Oxidative stress in severe acute illness

Redox Biology

Volumn 4, Issue , 2015, Pages 340-345

  Bar Or, David ^a,b,c   Bar Or, Raphael ^a,b,c   Rael, Leonard T ^a,b,c   Brody, Edward N ^d  

^a SWEDISH MEDICAL CENTER   (United States)

^b St Anthony Hospital   (United States)

^c Medical Center of Plano Trauma Services Department   (United States)

^d SomaLogic Inc   (United States)

Author keywords

4 Hydroxynonenal; Hypoxia inducible factor 1; Malondialdehyde; Oxidation reduction potential; Superoxide dismutase; Traumatic brain injury

Indexed keywords

CATALASE; LIPID; NUCLEIC ACID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; THIOREDOXIN;

ACUTE DISEASE; BLOOD OXYGEN TENSION; BRAIN HYPOXIA; BRAIN OXYGEN CONSUMPTION; CEREBROVASCULAR ACCIDENT; ENZYME BLOOD LEVEL; HEART INFARCTION; HUMAN; LIPID PEROXIDATION; MOLECULAR PATHOLOGY; MULTIPLE TRAUMA; NONHUMAN; NUCLEIC ACID METABOLISM; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PREDICTIVE VALUE; PROGNOSIS; PROTEIN METABOLISM; REDOX STRESS; REVIEW; SEPSIS; TRAUMATIC BRAIN INJURY; ANTAGONISTS AND INHIBITORS; BRAIN INJURIES; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; STROKE;

ACUTE DISEASE; ANTIOXIDANTS; BRAIN INJURIES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; MULTIPLE TRAUMA; MYOCARDIAL INFARCTION; NAD; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEPSIS; STROKE; SUPEROXIDE DISMUTASE; THIOREDOXINS;

EID: 84921935308     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.01.006     Document Type: Review

References (47)

1. Hwang C., Sinskey A.J., Lodish H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992, 257(5076):1496-1502. http://www.ncbi.nlm.nih.gov/pubmed/1523409, 10.1126/science.1523409.
2. Watson J.D. Type 2 diabetes as a redox disease. Lancet 2014, 383(9919):841-843. http://www.ncbi.nlm.nih.gov/pubmed/24581668, 10.1016/S0140-6736(13)62365-X.
3. Ottaviano F.G., Handy D.E., Loscalzo J. Redox regulation in the extracellular environment. Circulation Journal 2008, 72(1):1-16. http://www.ncbi.nlm.nih.gov/pubmed/18159092, 10.1253/circj.72.1.
4. Jones D.P., Carlson J.L., Mody V.C., Cai J., Lynn M.J., Sternberg P. Redox state of glutathione in human plasma. Free Radical Biology and Medicine 2000, 28(4):625-635. http://www.ncbi.nlm.nih.gov/pubmed/10719244, 10.1016/S0891-5849(99)00275-0.
5. Rael L.T., Bar-Or R., Mains C.W., Slone D.S., Levy A.S., Bar-Or D. Plasma oxidation-reduction potential and protein oxidation in traumatic brain injury. Journal of Neurotrauma 2009, 26(8):1203-1211. http://www.ncbi.nlm.nih.gov/pubmed/19317602, 10.1089/neu.2008-0816.
6. Rael L.T., Bar-Or R., Aumann R.M., Slone D.S., Mains C.W., Bar-Or D. Oxidation-reduction potential and paraoxonase-arylesterase activity in trauma patients. Biochemical and Biophysical Research Communications 2007, 361(2):561-565. http://www.ncbi.nlm.nih.gov/pubmed/17662690, 10.1016/j.bbrc.2007.07.078.
7. Rael L.T., Bar-Or R., Salottolo K., Mains C.W., Slone D.S., Offner P.J., Bar-Or D. Injury severity and serum amyloid A correlate with plasma oxidation-reduction potential in multi-trauma patients: a retrospective analysis. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:57. http://www.ncbi.nlm.nih.gov/pubmed/19925664, 10.1186/1757-7241-17-57.
8. Hayakawa H., Kuwano M., Sekiguchi M. Specific binding of 8-oxoguanine-containing RNA to polynucleotide phosphorylase protein. Biochemistry 2001, 40(33):9977-9982. http://www.ncbi.nlm.nih.gov/pubmed/11502194, 10.1021/bi010595q.
9. Hayakawa H., Sekiguchi M. Human polynucleotide phosphorylase protein in response to oxidative stress. Biochemistry 2006, 45(21):6749-6755. http://www.ncbi.nlm.nih.gov/pubmed/16716086, 10.1021/bi052585l.
10. McKinlay A., Gerard W., Fields S. Global analysis of RNA oxidation in Saccharomyces cerevisiae. BioTechniques 2012, 52(2):109-111. http://www.ncbi.nlm.nih.gov/pubmed/22313409, 10.2144/000113801.
11. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991, 11(1):81-128. http://www.ncbi.nlm.nih.gov/pubmed/1937131, 10.1016/0891-5849(91)90192-6.
12. Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncology 2012, 2012:137289. http://www.ncbi.nlm.nih.gov/pubmed/23119185, 10.5402/2012/137289.
13. Pizzimenti S., Toaldo C., Pettazzoni P., Dianzani M.U., Barrera G. The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers (Basel) 2010, 2(2):338-363. http://www.ncbi.nlm.nih.gov/pubmed/24281073, 10.3390/cancers2020338.
14. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends in Neurosciences 1998, 21(2):53-57. http://www.ncbi.nlm.nih.gov/pubmed/9498297, 10.1016/S0166-2236(97)01188-0.
15. Keller J.N., Mark R.J., Bruce A.J., Blanc E., Rothstein J.D., Uchida K., Waeg G., Mattson M.P. 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 1997, 80(3):685-696. http://www.ncbi.nlm.nih.gov/pubmed/9276486, 10.1016/S0306-4522(97)00065-1.
16. Zheng R., Dragomir A.C., Mishin V., Richardson J.R., Heck D.E., Laskin D.L., Laskin J.D. Differential metabolism of 4-hydroxynonenal in liver, lung and brain of mice and rats. Toxicology and Applied Pharmacology 2014, 279(1):43-52. http://www.ncbi.nlm.nih.gov/pubmed/24832492, 10.1016/j.taap.2014.04.026.
17. Iwai K., Drake S.K., Wehr N.B., Weissman A.M., LaVaute T., Minato N., Klausner R.D., Levine R.L., Rouault T.A. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(9):4924-4928. http://www.ncbi.nlm.nih.gov/pubmed/9560204, 10.1073/pnas.95.9.4924.
18. Bayir H., Kagan V.E., Tyurina Y.Y., Tyurin V., Ruppel R.A., Adelson P.D., Graham S.H., Janesko K., Clark R.S., Kochanek P.M. Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatric Research 2002, 51(5):571-578. http://www.ncbi.nlm.nih.gov/pubmed/11978879, 10.1203/00006450-200205000-00005.
19. Varma S., Janesko K.L., Wisniewski S.R., Bayir H., Adelson P.D., Thomas N.J., Kochanek P.M. F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children. Journal of Neurotrauma 2003, 20(8):781-786. http://www.ncbi.nlm.nih.gov/pubmed/12965056, 10.1089/089771503767870005.
20. Darwish R.S., Amiridze N., Aarabi B. Nitrotyrosine as an oxidative stress marker: evidence for involvement in neurologic outcome in human traumatic brain injury. Journal of Trauma 2007, 63(2):439-442. http://www.ncbi.nlm.nih.gov/pubmed/17693848, 10.1097/TA.0b013e318069178a.
21. Manevich Y., Hutchens S., Halushka P.V., Tew K.D., Townsend D.M., Jauch E.C., Borg K. Peroxiredoxin VI oxidation in cerebrospinal fluid correlates with traumatic brain injury outcome. Free Radical Biology and Medicine 2014, 72:210-221. http://www.ncbi.nlm.nih.gov/pubmed/24726861, 10.1016/j.freeradbiomed.2014.04.002.
22. Goode H.F., Cowley H.C., Walker B.E., Howdle P.D., Webster N.R. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Critical Care Medicine 1995, 23(4):646-651. http://www.ncbi.nlm.nih.gov/pubmed/7712754, 10.1097/00003246-199504000-00011.
23. Warner A., Bencosme A., Healy D., Verme C. Prognostic role of antioxidant enzymes in sepsis: preliminary assessment. Clinical Chemistry 1995, 41(6 1):867-871. http://www.ncbi.nlm.nih.gov/pubmed/7768006.
24. Cowley H.C., Bacon P.J., Goode H.F., Webster N.R., Jones J.G., Menon D.K. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Critical Care Medicine 1996, 24(7):1179-1183. http://www.ncbi.nlm.nih.gov/pubmed/8674332, 10.1097/00003246-199607000-00019.
25. Batra S., Kumar R., Kapoor A.K., Ray G. Alterations in antioxidant status during neonatal sepsis. Annals of Tropical Paediatrics 2000, 20(1):27-33. http://www.ncbi.nlm.nih.gov/pubmed/10824210, 10.1080/02724930092039.
26. Galley H.F. Oxidative stress and mitochondrial dysfunction in sepsis. British Journal of Anaesthesia 2011, 107(1):57-64. http://www.ncbi.nlm.nih.gov/pubmed/21596843, 10.1093/bja/aer093.
27. Murphy M.P. How mitochondria produce reactive oxygen species. Biochemical Journal 2009, 417(1):1-13. http://www.ncbi.nlm.nih.gov/pubmed/19061483, 10.1042/BJ20081386.
28. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(20):11715-11720. http://www.ncbi.nlm.nih.gov/pubmed/9751731, 10.1073/pnas.95.20.11715.
29. Guzy R.D., Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Experimental Physiology 2006, 91(5):807-819. http://www.ncbi.nlm.nih.gov/pubmed/16857720, 10.1113/expphysiol.2006.033506.
30. Tsai N.W., Chang Y.T., Huang C.R., Lin Y.J., Lin W.C., Cheng B.C., Su C.M., Chiang Y.F., Chen S.F., Huang C.C., Chang W.N., Lu C.H. Association between oxidative stress and outcome in different subtypes of acute ischemic stroke. BioMed Research International 2014, 2014:256879. http://www.ncbi.nlm.nih.gov/pubmed/24895559, 10.1155/2014/256879.
31. Szczepańska-Szerej A., Kurzepa J., Wojczal J., Stelmasiak Z. Simvastatin displays an antioxidative effect by inhibiting an increase in the serum 8-isoprostane level in patients with acute ischemic stroke: brief report. Clinical Neuropharmacology 2011, 34(5):191-194. http://www.ncbi.nlm.nih.gov/pubmed/21897213, 10.1097/WNF.0b013e3182309418.
32. Sánchez-Moreno C., Dashe J.F., Scott T., Thaler D., Folstein M.F., Martin A. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2004, 35(1):163-168. http://www.ncbi.nlm.nih.gov/pubmed/14671251, 10.1161/01.STR.0000105391.62306.2E.
33. Jurcau A. The role of antioxidant treatment in acute ischemic stroke: a clinical study. Romanian Journal of Neurology 2007, 6:181-188.
34. Ullegaddi R., Powers H.J., Gariballa S.E. Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. European Journal of Clinical Nutrition 2005, 59(12):1367-1373. http://www.ncbi.nlm.nih.gov/pubmed/16091766, 10.1038/sj.ejcn.1602248.
35. Ullegaddi R., Powers H.J., Gariballa S.E. B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke. Clinical Science (London) 2004, 107(5):477-484. http://www.ncbi.nlm.nih.gov/pubmed/15279619, 10.1042/CS20040134.
36. Gaetani P., Pasqualin A., Rodriguez y Baena R., Borasio E., Marzatico F. Oxidative stress in the human brain after subarachnoid hemorrhage. Journal of Neurosurgery 1998, 89(5):748-754. http://www.ncbi.nlm.nih.gov/pubmed/9817412, 10.3171/jns.1998.89.5.0748.
37. Hill M.F., Singal P.K. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997, 96(7):2414-2420. http://www.ncbi.nlm.nih.gov/pubmed/9337218, 10.1161/01.CIR.96.7.2414.
38. Palace V.P., Hill M.F., Farahmand F., Singal P.K. Mobilization of antioxidant vitamin pools and hemodynamic function after myocardial infarction. Circulation 1999, 99(1):121-126. http://www.ncbi.nlm.nih.gov/pubmed/9884388, 10.1161/01.CIR.99.1.121.
39. Di Filippo C., Cuzzocrea S., Rossi F., Marfella R., D'Amico M. Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovascular Drug Reviews 2006, 24(2):77-87. http://www.ncbi.nlm.nih.gov/pubmed/16961722, 10.1111/j.1527-3466.2006.00077.x.
40. Erickson J.R., He B.J., Grumbach I.M., Anderson M.E. CaMKII in the cardiovascular system: sensing redox states. Physiological Reviews 2011, 91(3):889-915. http://www.ncbi.nlm.nih.gov/pubmed/21742790, 10.1152/physrev.00018.2010.
41. Luo M., Guan X., Luczak E.D., Lang D., Kutschke W., Gao Z., Yang J., Glynn P., Sossalla S., Swaminathan P.D., Weiss R.M., Yang B., Rokita A.G., Maier L.S., Efimov I.R., Hund T.J., Anderson M.E. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. Journal of Clinical Investigation 2013, 123(3):1262-1274. http://www.ncbi.nlm.nih.gov/pubmed/23426181, 10.1172/JCI65268.
42. Samuel S.M., Thirunavukkarasu M., Penumathsa S.V., Koneru S., Zhan L., Maulik G., Sudhakaran P.R., Maulik N. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation 2010, 121(10):1244-1255. http://www.ncbi.nlm.nih.gov/pubmed/20194885, 10.1161/CIRCULATIONAHA.109.872481.
43. Rodrigo R., Hasson D., Prieto J.C., Dussaillant G., Ramos C., León L., Gárate J., Valls N., Gormaz J.G. The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial. Trials 2014, 15:192. http://www.ncbi.nlm.nih.gov/pubmed/24885600, 10.1186/1745-6215-15-192.
44. Chouchani E.T., Pell V.R., Gaude E., Aksentijević D., Sundier S.Y., Robb E.L., Logan A., Nadtochiy S.M., Ord E.N., Smith A.C., Eyassu F., Shirley R., Hu C.H., Dare A.J., James A.M., Rogatti S., Hartley R.C., Eaton S., Costa A.S., Brookes P.S., Davidson S.M., Duchen M.R., Saeb-Parsy K., Shattock M.J., Robinson A.J., Work L.M., Frezza C., Krieg T., Murphy M.P. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014, 515(7527):431-435. http://www.ncbi.nlm.nih.gov/pubmed/25383517, 10.1038/nature13909.
45. Pepper J.R., Mumby S., Gutteridge J.M. Sequential oxidative damage, and changes in iron-binding and iron-oxidising plasma antioxidants during cardiopulmonary bypass surgery. Free Radical Research 1994, 21(6):377-385. http://www.ncbi.nlm.nih.gov/pubmed/7834052, 10.3109/10715769409056590.
46. Rock C.L., Dechert R.E., Khilnani R., Parker R.S., Rodriguez J.L. Carotenoids and antioxidant vitamins in patients after burn injury. Journal of Burn Care & Rehabilitation 1997, 18(3):269-278. [Discussion 268]. http://www.ncbi.nlm.nih.gov/pubmed/9169953, 10.1097/00004630-199705000-00018.
47. Henrich D., Zimmer S., Seebach C., Frank J., Barker J., Marzi I. Trauma-activated polymorphonucleated leukocytes damage endothelial progenitor cells: probable role of CD11b/CD18-CD54 interaction and release of reactive oxygen species. Shock 2011, 36(3):216-222. http://www.ncbi.nlm.nih.gov/pubmed/21610569, 10.1097/SHK.0b013e3182236eba.